Amblyopia Treatment for Children Aged 8 to 12 Years Using Curesight12 Device

What this Trial Is About

This research aims to evaluate the effect of at-home amblyopia treatment with Curesight12 for children aged 8 to 12 years who have residual amblyopia. Amblyopia, or lazy eye, is a vision disorder where the brain doesn't process images well from one eye, leading to decreased vision. While treatments like glasses and patching help younger children, many older children still experience vision problems, so new treatments for this age group are needed to improve quality of life and reduce lifelong vision risks. The treatment uses the Curesight12 system, which includes an 11.6-inch tablet, an eye tracker, red-cyan glasses, and software that streams videos with special visual effects to encourage the amblyopic eye to work better. Children watch videos of their choice at home while the system blurs part of the stronger eye's view to stimulate the weaker eye. The device adjusts the blur based on each child's vision, and the study will assess how effective this approach is for older children aged 8 to 12. Participants will be involved for at least 12 weeks, during which researchers will measure improvements in the visual acuity of the amblyopic eye compared to their starting vision. The study includes eye exams and vision tests to monitor progress and to adjust the treatment as needed. Data is securely stored and managed following privacy standards. This pilot study follows previous trials in younger children and aims to provide insight into Curesight12's benefits for this older age group.

Amblyopia Treatment for Children Aged 8 to 12 Years